Free Trial

Inspire Medical Systems (INSP) Stock Price, News & Analysis

+9.18 (+6.02%)
(As of 05/22/2024 ET)
Today's Range
50-Day Range
52-Week Range
628,332 shs
Average Volume
807,177 shs
Market Capitalization
$4.80 billion
P/E Ratio
Dividend Yield
Price Target

Inspire Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.69 Rating Score
58.8% Upside
$256.53 Price Target
Short Interest
7.74% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
1.22mentions of Inspire Medical Systems in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$15.66 M Sold Last Quarter
Proj. Earnings Growth
From $0.16 to $0.81 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.93 out of 5 stars

Medical Sector

26th out of 920 stocks

Surgical & Medical Instruments Industry

7th out of 96 stocks

INSP stock logo

About Inspire Medical Systems Stock (NYSE:INSP)

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Stock Price History

INSP Stock News Headlines

Inspire: Q1 Earnings Snapshot
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
16 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$624.80 million
Book Value
$19.83 per share


Free Float
Market Cap
$4.80 billion
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

INSP Stock Analysis - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price target for 2024?

16 brokers have issued 12 month price targets for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they anticipate the company's share price to reach $256.53 in the next twelve months. This suggests a possible upside of 58.8% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2024?

Inspire Medical Systems' stock was trading at $203.43 at the beginning of the year. Since then, INSP shares have decreased by 20.6% and is now trading at $161.55.
View the best growth stocks for 2024 here

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our INSP earnings forecast

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) posted its earnings results on Tuesday, May, 7th. The company reported ($0.34) EPS for the quarter, topping analysts' consensus estimates of ($0.63) by $0.29. The company had revenue of $164.01 million for the quarter, compared to the consensus estimate of $161.41 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 2.82% and a negative net margin of 2.38%. The business's revenue was up 28.2% on a year-over-year basis. During the same period in the previous year, the business earned ($0.53) EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of 0.100-0.200 for the period, compared to the consensus EPS estimate of -0.360. The company issued revenue guidance of $783.0 million-$793.0 million, compared to the consensus revenue estimate of $782.3 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

Inspire Medical Systems (INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.55%), Baillie Gifford & Co. (4.84%), Wasatch Advisors LP (3.64%), William Blair Investment Management LLC (2.50%), Champlain Investment Partners LLC (2.16%) and Bank of New York Mellon Corp (1.97%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:INSP) was last updated on 5/23/2024 by Staff

From Our Partners